Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AVNS NYSE:MSA OTCMKTS:SHWGF OTCMKTS:WILYY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$24.70-0.2%$19.45$9.30▼$24.91$1.16B1.581.17 million shs1.35 million shsMSAMSA Safety Incorporporated$168.45-0.3%$170.47$151.10▼$208.92$6.52B0.97287,579 shs218,207 shsSHWGFShandong Weigao Medical Polymer$0.44$0.53$0.44▼$0.73$1.98B-0.2551,340 shsN/AWILYYDemant A/S$18.05$15.75$13.45▼$21.93$7.64B1.13191 shs18 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical-0.20%-0.04%+0.28%+59.65%+94.45%MSAMSA Safety Incorporporated-0.40%-3.42%-2.01%-14.50%+6.96%SHWGFShandong Weigao Medical Polymer0.00%0.00%-2.34%-39.17%-42.23%WILYYDemant A/S0.00%0.00%+5.43%+27.74%-10.64%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$24.70-0.2%$19.45$9.30▼$24.91$1.16B1.581.17 million shs1.35 million shsMSAMSA Safety Incorporporated$168.45-0.3%$170.47$151.10▼$208.92$6.52B0.97287,579 shs218,207 shsSHWGFShandong Weigao Medical Polymer$0.44$0.53$0.44▼$0.73$1.98B-0.2551,340 shsN/AWILYYDemant A/S$18.05$15.75$13.45▼$21.93$7.64B1.13191 shs18 shs The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical-0.20%-0.04%+0.28%+59.65%+94.45%MSAMSA Safety Incorporporated-0.40%-3.42%-2.01%-14.50%+6.96%SHWGFShandong Weigao Medical Polymer0.00%0.00%-2.34%-39.17%-42.23%WILYYDemant A/S0.00%0.00%+5.43%+27.74%-10.64%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVNSAvanos Medical 1.00SellN/AN/AMSAMSA Safety Incorporporated 2.29Hold$200.0018.73% UpsideSHWGFShandong Weigao Medical Polymer 2.00HoldN/AN/AWILYYDemant A/S 3.33BuyN/AN/ACurrent Analyst Ratings BreakdownLatest MSA, SHWGF, WILYY, and AVNS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/11/2026MSAMSA Safety Incorporporated DA DavidsonSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$235.00 ➝ $206.005/7/2026AVNSAvanos Medical Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell5/6/2026MSAMSA Safety Incorporporated Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$197.004/26/2026SHWGFShandong Weigao Medical Polymer The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeNeutral4/22/2026AVNSAvanos Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/6/2026MSAMSA Safety Incorporporated Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B-) ➝ Hold (C+)3/31/2026MSAMSA Safety Incorporporated Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$200.00 ➝ $180.003/30/2026MSAMSA Safety Incorporporated Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$205.00 ➝ $195.003/18/2026WILYYDemant A/S Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy(Data available from 5/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVNSAvanos Medical$701.20M1.65$3.42 per share7.22$16.70 per share1.48MSAMSA Safety Incorporporated$1.87B3.47$9.77 per share17.25$35.02 per share4.81SHWGFShandong Weigao Medical Polymer$1.82B1.09$0.09 per share4.73$0.78 per share0.57WILYYDemant A/S$3.48B2.20$0.88 per share20.54$3.51 per share5.14Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVNSAvanos Medical-$72.90M-$1.61N/A26.55N/A-10.39%5.39%3.97%8/4/2026 (Estimated)MSAMSA Safety Incorporporated$278.92M$7.4022.7617.40N/A15.16%24.54%12.64%8/3/2026 (Estimated)SHWGFShandong Weigao Medical Polymer$314.90MN/AN/AN/AN/AN/AN/AN/AN/AWILYYDemant A/S$233.91MN/AN/AN/AN/AN/AN/AN/A5/27/2026 (Estimated)Latest MSA, SHWGF, WILYY, and AVNS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/5/2026Q1 2026AVNSAvanos Medical$0.16$0.22+$0.06$0.11$170.00 million$182.20 million5/4/2026Q1 2026MSAMSA Safety Incorporporated$1.85$1.99+$0.14$1.83$451.28 million$463.63 million2/24/2026Q4 2025AVNSAvanos Medical$0.24$0.29+$0.05-$0.03$174.70 million$180.90 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAVNSAvanos MedicalN/AN/AN/AN/AN/AMSAMSA Safety Incorporporated$2.161.28%+4.19%29.19%56 YearsSHWGFShandong Weigao Medical PolymerN/AN/AN/AN/AN/AWILYYDemant A/SN/AN/AN/AN/AN/ALatest MSA, SHWGF, WILYY, and AVNS DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/4/2026MSAMSA Safety Incorporporatedquarterly$0.541.26%5/15/20265/15/20266/10/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVNSAvanos Medical0.112.481.40MSAMSA Safety Incorporporated0.453.171.92SHWGFShandong Weigao Medical PolymerN/AN/AN/AWILYYDemant A/S1.651.361.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVNSAvanos Medical95.17%MSAMSA Safety Incorporporated92.51%SHWGFShandong Weigao Medical PolymerN/AWILYYDemant A/SN/AInsider OwnershipCompanyInsider OwnershipAVNSAvanos Medical2.33%MSAMSA Safety Incorporporated0.70%SHWGFShandong Weigao Medical PolymerN/AWILYYDemant A/SN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVNSAvanos Medical2,28746.83 million45.73 millionOptionableMSAMSA Safety Incorporporated5,30038.60 million38.33 millionOptionableSHWGFShandong Weigao Medical Polymer12,7194.49 billionN/ANot OptionableWILYYDemant A/S26,704423.51 millionN/ANot OptionableMSA, SHWGF, WILYY, and AVNS HeadlinesRecent News About These CompaniesReviewing Demant A/S (OTCMKTS:WILYY) & Maravai LifeSciences (NASDAQ:MRVI)May 21 at 3:49 AM | americanbankingnews.comDemant shares surge 15% after Oticon Zeal drives Q1 growthMay 7, 2026 | za.investing.comDemant A/S (OTCMKTS:WILYY) Sees Unusually-High Trading Volume - Here's WhyMay 6, 2026 | marketbeat.comDemant A/S: Expansion of Demant's Executive Leadership TeamMay 6, 2026 | finanznachrichten.deDemant A/S (OTCMKTS:WILYY) Shares Gap Down - Should You Sell?April 27, 2026 | marketbeat.comDemant A/S Unsponsored ADR (OTCMKTS:WILYY) Sees Significant Decrease in Short InterestApril 25, 2026 | marketbeat.comJefferies flips on hearing aid giants, upgrades Demant, cuts SonovaMarch 18, 2026 | investing.com3 European Stocks Estimated To Be Trading At Over 49.3% Below Intrinsic ValueFebruary 18, 2026 | finance.yahoo.comDemant tops Q4 forecasts on Diagnostics recovery, but shares tumble on outlookFebruary 4, 2026 | investing.comDemant A/S (WILYY) Q4 2025 Earnings Call TranscriptFebruary 3, 2026 | seekingalpha.comDemant price target lowered to DKK 288 from DKK 291 at JPMorganDecember 16, 2025 | msn.comDemant downgraded to equal weight from overweight at Morgan StanleyDecember 15, 2025 | msn.com'Words that carry weight, carry mana': Demant talks World Cup disappointment and BearsNovember 27, 2025 | rugbypass.comR'Breath of fresh air' to play in PWR - DemantNovember 27, 2025 | msn.comDemant A/S: Investor news - Demant obtains regulatory approval for the acquisition of KINDNovember 19, 2025 | finanznachrichten.deDemant initiated with a Sector Perform at RBC CapitalNovember 18, 2025 | msn.comBlack Ferns star Ruahei Demant heading to BritainNovember 18, 2025 | msn.comRuahei Demant Heads to Bristol Before 2026 ReturnNovember 18, 2025 | allblacks.comABristol Bears confirm signing of ‘genuinely world class’ Ruahei DemantNovember 18, 2025 | rugbypass.comRBlack Ferns star Ruahei Demant to join Bristol BearsNovember 18, 2025 | bristol247.comBBlack Fern Demant to join Bristol on short-term dealNovember 18, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMSA, SHWGF, WILYY, and AVNS Company DescriptionsAvanos Medical NYSE:AVNS$24.70 -0.05 (-0.18%) Closing price 05/21/2026 03:59 PM EasternExtended Trading$24.71 +0.02 (+0.06%) As of 05/21/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.MSA Safety Incorporporated NYSE:MSA$168.45 -0.51 (-0.30%) Closing price 05/21/2026 03:59 PM EasternExtended Trading$168.61 +0.16 (+0.09%) As of 05/21/2026 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.MSA Safety Incorporated develops, manufactures, and supplies safety products and technology solutions that protect people and facility infrastructures in the fire service, energy, utility, construction, and industrial manufacturing applications, as well as heating, ventilation, air conditioning, and refrigeration industries worldwide. The company's core product offerings include fixed gas and flame detection systems, such as gas detection monitoring systems, and flame detectors and open-path infrared gas detectors; breathing apparatus products, including self-contained breathing apparatus; hand-held portable gas detection instruments to detect the presence or absence of various gases in the air; industrial head protection products; firefighter helmets and protective apparel; and fall protection equipment, such as confined space equipment, harnesses, lanyards, and self-retracting lifelines, as well as engineered systems. In addition, the company offers air-purifying respirators, eye and face protection products, ballistic helmets, and gas masks. It serves distributors and end-users through indirect and direct sales channels. The company offers its products under the V-Gard, Cairns, and Gallet brand names. MSA Safety Incorporated was founded in 1914 and is based in Cranberry Township, Pennsylvania.Shandong Weigao Medical Polymer OTCMKTS:SHWGF$0.44 0.00 (0.00%) As of 05/20/2026Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables. It also provides tumour and blood vessel interventional instruments; flushing syringes; blood collection, irradiation, storage, separation and sterilization products; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture Instruments; medicines; and X-ray based irradiation machines. In addition, it is involved in the finance leasing and factoring business; provision of enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.Demant A/S OTCMKTS:WILYY$18.05 0.00 (0.00%) As of 05/19/2026Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending Target Shows Strengths, But Analysts Want to See More Freight Boom: The Hormuz Blockade Payday TJX Companies Fires on All Cylinders With 9% Revenue Growth Analog Devices Provides Much-Needed Pullback: How Low Can It Go? USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms From Zepbound to Foundayo: Lilly's Latest Results Support Oral GLP-1 Outlook Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
